Tapering biologic therapy for people with rheumatoid arthritis in remission: A review of patient perspectives and associated clinical evidence-Reference-Cited by-同舟云学术

Tapering biologic therapy for people with rheumatoid arthritis in remission: A review of patient perspectives and associated clinical evidence

Published:2019-05-30 Issue:3 Volume:17 Page:161-169
ISSN:1478-2189
Container-title:Musculoskeletal Care
language:en
Short-container-title:Musculoskeletal Care

Author:

Stamp Lisa K.¹,Chan Suz Jack²,Marra Carlo²,Helme Caitlin³,Treharne Gareth J.³^ORCID

Affiliation:

1. Department of MedicineUniversity of Otago Christchurch Aotearoa/New Zealand

2. School of PharmacyUniversity of Otago Dunedin Aotearoa/New Zealand

3. Department of PsychologyUniversity of Otago Dunedin Aotearoa/New Zealand

Publisher

Wiley

Subject

Nursing (miscellaneous),Rehabilitation,Physical Therapy, Sports Therapy and Rehabilitation,Orthopedics and Sports Medicine,Chiropractics,Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/msc.1404

Reference48 articles.

1. Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients

2. Arthritis Consumer Experts. (2018).Arthritis Medications Report Card. Where does your province rank?Retrieved fromhttp://jointhealth.org/programs‐jhreportcard.cfm?locale=en‐CA

3. Development and preliminary user testing of the DCIDA (Dynamic computer interactive decision application) for ‘nudging’ patients towards high quality decisions;Bansback N.;BMC Medical Informatics and Decision Making,2014

4. Inequity in access to bDMARD care and how it influences disease outcomes across countries worldwide: Results from the METEOR‐registry;Bergstra S.;Annals of the Rheumatic Diseases,2018

5. Prediction of successful dose reduction or discontinuation of adalimumab, etanercept, or infliximab in rheumatoid arthritis patients using serum drug levels and antidrug antibody measurement

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients' and rheumatologists' perceptions on dose reduction of rituximab in rheumatoid arthritis;Musculoskeletal Care;2024-05

2. Acceptability of ‘as needed’ biologic therapy in psoriasis: insights from a multistakeholder mixed-methods study;British Journal of Dermatology;2024-02-17

3. Patient perspectives on tapering biologic or targeted synthetic therapy in well-controlled rheumatoid arthritis and comparison with providers’ perspectives;Rheumatology;2023-10-01

4. Treatment patterns of individualized real-life tapering approaches based on shared decision-making in rheumatoid arthritis;Zeitschrift für Rheumatologie;2023-06-23

5. Tapering biologic DMARDs in rheumatoid arthritis;Current Opinion in Pharmacology;2022-12